Cumberland Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.66M | Buy |
25,102
+1,545
| +7% | +$287K | 0.32% | 58 |
|
|
2025
Q1 | $4.94M | Buy |
23,557
+4,175
| +22% | +$875K | 0.38% | 52 |
|
|
2024
Q4 | $3.44M | Sell |
19,382
-8,615
| -31% | -$1.53M | 0.24% | 67 |
|
|
2024
Q3 | $5.53M | Sell |
27,997
-14,850
| -35% | -$2.93M | 0.38% | 54 |
|
|
2024
Q2 | $7.35M | Buy |
42,847
+14,395
| +51% | +$2.47M | 0.53% | 42 |
|
|
2024
Q1 | $5.18M | Buy |
+28,452
| New | +$5.18M | 0.38% | 55 |
|
|
2023
Q3 | – | Sell |
-20,262
| Closed | -$2.73M | – | 172 |
|
|
2023
Q2 | $2.73M | Buy |
20,262
+14,560
| +255% | +$1.96M | 0.25% | 75 |
|
|
2023
Q1 | $909K | Sell |
5,702
-30,790
| -84% | -$4.91M | 0.09% | 108 |
|
|
2022
Q4 | $5.9M | Sell |
36,492
-16,980
| -32% | -$2.74M | 0.62% | 35 |
|
|
2022
Q3 | $7.18M | Buy |
53,472
+10,085
| +23% | +$1.35M | 0.76% | 33 |
|
|
2022
Q2 | $6.65M | Buy |
43,387
+20,925
| +93% | +$3.21M | 0.63% | 41 |
|
|
2022
Q1 | $3.64M | Buy |
22,462
+14,012
| +166% | +$2.27M | 0.28% | 70 |
|
|
2021
Q4 | $1.14M | Buy |
+8,450
| New | +$1.14M | 0.08% | 122 |
|
|
2019
Q1 | – | Sell |
-7,000
| Closed | -$645K | – | 162 |
|
|
2018
Q4 | $645K | Buy |
7,000
+115
| +2% | +$10.6K | 0.07% | 117 |
|
|
2018
Q3 | $651K | Sell |
6,885
-7,650
| -53% | -$723K | 0.06% | 125 |
|
|
2018
Q2 | $1.35M | Buy |
+14,535
| New | +$1.35M | 0.14% | 91 |
|